PTC THERAPEUTICS INC's ticker is and the CUSIP is 69366JAB7. A total of 18 filers reported holding PTC THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $1,681,000 | -65.4% | 1,672,000 | -64.2% | 0.05% | -58.9% |
| Q1 2022 | $4,858,000 | -2.1% | 4,672,000 | 0.0% | 0.11% | +10.9% |
| Q4 2021 | $4,964,000 | +12.0% | 4,672,000 | +9.8% | 0.10% | +4.1% |
| Q3 2021 | $4,432,000 | +224.2% | 4,254,000 | +239.2% | 0.10% | +212.9% |
| Q2 2021 | $1,367,000 | -47.3% | 1,254,000 | -44.4% | 0.03% | -49.2% |
| Q1 2021 | $2,595,000 | -10.5% | 2,254,000 | 0.0% | 0.06% | -17.6% |
| Q4 2020 | $2,901,000 | +12.9% | 2,254,000 | 0.0% | 0.07% | -2.6% |
| Q3 2020 | $2,570,000 | -3.1% | 2,254,000 | 0.0% | 0.08% | -9.5% |
| Q2 2020 | $2,653,000 | +3.3% | 2,254,000 | -2.0% | 0.08% | -7.7% |
| Q1 2020 | $2,569,000 | -2.9% | 2,300,000 | 0.0% | 0.09% | +21.3% |
| Q4 2019 | $2,645,000 | +11.1% | 2,300,000 | 0.0% | 0.08% | +2.7% |
| Q3 2019 | $2,381,000 | – | 2,300,000 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 24,877,000 | $25,902,000 | 1.06% |
| PFM Health Sciences, LP | 19,807,000 | $20,605,000 | 0.61% |
| Partner Investment Management, L.P. | 193,000 | $201,000 | 0.34% |
| DeepCurrents Investment Group LLC | 4,430,000 | $4,581,000 | 0.31% |
| WOLVERINE ASSET MANAGEMENT LLC | 20,454,000 | $21,253,000 | 0.27% |
| FARALLON CAPITAL MANAGEMENT LLC | 24,176,000 | $25,210,000 | 0.19% |
| PALISADE CAPITAL MANAGEMENT, LP | 2,300,000 | $2,381,000 | 0.07% |
| Verition Fund Management LLC | 1,415,000 | $1,472,000 | 0.04% |
| CAPSTONE INVESTMENT ADVISORS, LLC | 4,298,000 | $4,470,000 | 0.03% |
| LOOMIS SAYLES & CO L P | 248,482 | $8,404,000 | 0.02% |